Answers are grounded in this paper and cite their sources.
Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD) has been associated with increased cardiovascular risk. The aim of this Randomized Double-blind clinical Trial was to evaluate the effects of coenzyme-Q10 supplementation in patients with MASLD in terms of endothelial, vascular and myocardial function.
No takes yet. Share an insight, caveat, or question.
Vrentzos et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: